Preventing Medication and Medical Device Errors

Adverse drug events (ADEs) result in more than 770,000 injuries and deaths each year and cost up to $5.6 million per hospital, depending on size. Patient injuries that result from prescribed drugs are among the most common patient safety errors. The outcomes of these events can range from a rash that clears up quickly to a patient death.

On the national level, a number of organizations and agencies have been working to decrease medication errors.

In addition to adopting the recommendations from The Joint Commission about certain abbreviations that should not be used when prescribing, the Institute for Healthcare Improvement has several guides for patient safety in general, and for preventing adverse drug events as well as preventing harm from high-alert medications. They also have available (free) on their website a paper titled, “Respectful Management of Serious Clinical Adverse Events”. The Institute for Safe Medication Practices (ISMP), based in suburban Philadelphia, is the nation’s only 501c (3) nonprofit organization devoted entirely to medication error prevention and safe medication use. They provide resources that can be used for “impartial, timely, and accurate medication information.”

Adverse events are those with undesirable effects for patients resulting from any medical product. These must be reported to the Food and Drug Administration if:

  • A patient’s death is suspected of being the result of the adverse event.
  • A patient was at a substantial risk of dying at the time of the adverse event or it is suspected that the use or continued use of the product would result in the patient's death.
  • Admission to a hospital or a hospital stay is prolonged as a result of the adverse event.
  • The adverse event resulted in a significant, persistent, or permanent change, impairment, damage or disruption in the patient's body function/structure, physical activities or quality of life.
  • There are suspicions that exposure to a medical product prior to conception or during pregnancy resulted in an adverse outcome in the child.
  • You suspect that the use of a medical product may result in a condition which required medical or surgical intervention to preclude permanent impairment or damage to a patient.

References: Preventing Errors from Drugs and Medical Devices

  • Appendix B: Adverse Event Definitions. Adverse Event Annual Reporting: Annual Report. February 2010. Pages 19-22. Retrieved March 22, 2010 from www.doh.wa.gov/search.htm?q=adverse+events.
  • “How-to Guide: Prevent Adverse Drug Events. Institute for Healthcare Improvement. www.ihi.org/NR/rdonlyres/98096387-C903-4252-8276-5BFC181C0C7F/0/ADEHowtoGuide.doc. Accessed October 24, 2010.
  • How-to Guide: Preventing Harm from High Alert Medications. Institute for Healthcare Improvement. www.iorg/NR/rdonlyres/8B2475CD-56C7-4D9B-B359-801F3CC3A8D5/0/HighAlertMedicationsHowToguide.doc. Accessed October 24, 2010.
  • Implementation: Tips for Avoiding Dangerous Abbreviations. The Joint Commission. (2006). Retrieved March 15, 2010 from www.jointcommission.org/PatientSafety/NationalPatientSafetyGoals/abbr_tips.htm.
  • Institute for Healthcare Improvement. How-to Guide: Preventing Adverse Drug Events. How-to Guide: Preventing Harm from High Alert Medications. Retrieved March 15, 2010 from www.ihi.org/IHI/Topics/Patient Safety/MedicationSystems.
  • Institute for Safe Medication Practices. Retrieved March 15, 2010 from www.ismp.org/.
  • Medication Errors Report and Recommendations. Washington State Department of Health. (December, 2000). Retrieved March 15, 2010 from www.doh.wa.gov/PatientSafety/document/Reportfinal.doc.
  • Medication Safety Initiative. Washington Patient Safety Coalition: A Program of the Foundation for Healthcare Quality. Retrieved March 16, 2010 from www.wapatientsafety.org/activities/msi.html.
  • Patient Safety Topics. www.ihi.org/IHI/Topics/PatientSafety/. Accessed October 24, 2010.
  • Reducing and Preventing Adverse Drug Events to Decrease Hospital Costs. AHRQ. Research in Action. Issue 1. Retrieved March 15, 2010 from www.ahrq.gov/qual/aderia/aderia.htm.
  • The Official List of “Do Not Use” Abbreviations. The Joint Commission.  www.jointcommission.org/PatientSafety/DoNotUseList/. Accessed October 24, 2010.
  • What is a Serious Adverse Event? How to Report. U.S. Food and Drug Administration. Retrieved March 22, 2010 from www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm.

Founded in 1908, WSNA is the professional organization representing more than 16,000 registered nurses in Washington State. WSNA effectively advocates for the improvement of health standards and availability of quality health care for all people; promotes high standards for the nursing profession; and advances the professional and economic development of nurses.

More Information...

WSNA Logo
Washington State Nurses Association
575 Andover Park West, Suite 101
Seattle, WA 98188
206.575.7979    |    206.575.1908 fax
© 2005-2013.   All rights reserved.    |    Privacy Policy    |    Site Map

The Washington State Nurses Association Continuing Education Provider Program (OH-231, 9-1-2012) is an approved provider of continuing nursing education by the Ohio Nurses Association (OBN-001-91), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.